Secukinumab psoriatic arthritis phase 3

New two-year data for Novartis’ investigational,New Novartis two-year data for investigational secukinumab,Psoriatic Arthritis and Connection to Diet: an,Secukinumab in TNF-IR Psoriasis Patients – Psoriasis Info,Novartis AG 2017 Q1 – Results – Earnings Call Slides,Secukinumab, a human anti-interleukin-17A monoclonal,Frontiers | Anti-IL17A in Axial Spondyloarthritis—Where,Pathological Role of Interleukin-6 in Psoriatic Arthritis,Tofacitinib attenuates pathologic immune pathways in,Top News From ACR 2014: Slideshow,Secukinumab, a human anti-interleukin-17A monoclonal,De nouvelles données issues d’une étude de Novartis menée,.

.

Originally posted 2017-06-26 12:57:06.